Goldman’s profit roughly doubled in Q4 thanks in large part to surging revenues from deal-making, underwriting, and trading.
The note reveals that Goldman has initiated coverage with a buy rating and $48.90 price target on ResMed's shares. Based on ...
The Bank of New York Mellon Corporation (NYSE:BK) shares are trading slightly lower on Thursday. Yesterday, the company ...
Goldman Sachs' credit-card partnership with Apple may end before its contract runs out in 2030, Goldman CEO David Solomon ...
Stephany Kirkpatrick took a career risk when she turned down a job at Goldman Sachs and joined SoulCycle. She says it ...
Shares in Tesla Inc. ( TSLA, Financial) fell near 3% in Thursday's morning trading, while Goldman Sachs reaffirmed its ...
Goldman Sachs is one of the biggest investment banker “book runners” for IPOs – where banks are paid many millions of dollars ...
Samantha Dart, Goldman Sachs co-head of global commodities research, joins 'Squawk Box' to discuss the state of the energy ...